CRISPR Therapeutics AG Investor Relations Material
CRISPR Therapeutics AG is a biopharmaceutical company focused on the development of transformative gene-based medicines with a portfolio of CRISPR/Cas9 leads in hemoglobinopathies, oncology, regenerative medicine, and rare diseases. It's products include CTX001, CTX101 and CTX110. The company was founded in July 2013 and is headquartered in Zug, Switzerland
Latest company events
Ticker symbol
CRSP
Country
United States of America
About the company
Investor Relations Page
Dig deeper into the CRISPR Therapeutics AG fundamentals on Quartr.
- Skip straight to the Q&A session
- Receive notifications about new events
- Connect the financial calender on your phone
- Figure out why the stock is up or down
- Read the transcripts or scroll the deck
- Access earnings or press releases
